Augmenting Anti-Tumor Immune Responses with Epigenetic Modifying Agents
Epigenetic silencing of immune-related genes is a striking feature of the cancer genome that occurs in the process of tumorigenesis. This phenomena impacts antigen processing and antigen presentation by tumor cells and facilitates evasion of immunosurveillance. Further modulation of the tumor microe...
Main Authors: | Erika eHeninger, Timothy eKrueger, Joshua M. Lang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00029/full |
Similar Items
-
The Status and Prospects of Epigenetics in the Treatment of Lymphoma
by: Jiaxin Liu, et al.
Published: (2022-04-01) -
Epigenetic Alterations in Alzheimer's Disease
by: Johannes eGräff, et al.
Published: (2015-12-01) -
Epigenetics and Early Development
by: Gokul Gopinathan, et al.
Published: (2022-06-01) -
The epigenetics of breast cancer – Opportunities for diagnostics, risk stratification and therapy
by: Rieke Schröder, et al.
Published: (2022-06-01) -
Epigenetics as a Therapeutic Target in Osteoarthritis
by: Carmen Núñez-Carro, et al.
Published: (2023-01-01)